Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.3000
-0.0050 (-1.67%)
Aug 8, 2025, 3:02 PM AEST
Theseus Pharmaceuticals Market Cap
Nyrada has a market cap or net worth of 63.44 million as of August 7, 2025. Its market cap has increased by 596.31% in one year.
Market Cap
63.44M
Enterprise Value
57.72M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 63.44M, an increase of 146.79%. That is a compound annual growth rate of 17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 63.44M | 220.85% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | 26.25M | 2.13% |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.54B |
| Pro Medicus | 33.39B |
| Cochlear | 20.52B |
| Sonic Healthcare | 13.66B |
| Ramsay Health Care | 8.66B |
| Telix Pharmaceuticals | 6.27B |
| Ansell | 4.43B |
| Mesoblast | 3.11B |